BioNTech SE
(BNTX)
undefined
undefined%
At close: undefined
121.57
1.14%
After-hours Dec 13, 2024, 05:44 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 3.82B | 17.31B | 18.98B | 482.32M | 108.59M | 127.58M | 61.60M |
Cost of Revenue | 599.80M | 4.53B | 3.86B | 704.36M | 243.83M | 156.73M | 94.81M |
Gross Profit | 3.22B | 12.78B | 15.12B | -222.04M | -135.24M | -29.16M | -33.22M |
Operating Income | 690.40M | 12.64B | 15.28B | -82.42M | -181.52M | -53.85M | -61.28M |
Interest Income | 357.60M | 330.30M | 1.50M | 1.56M | 1.78M | 2.00M | 2.13M |
Pretax Income | 1.19B | 12.95B | 15.05B | -145.80M | -179.44M | -47.66M | -85.91M |
Net Income | 930.30M | 9.43B | 10.29B | 15.20M | -179.17M | -48.02M | -85.65M |
Selling & General & Admin | 557.70M | 544.20M | 328.90M | 108.56M | 43.41M | 27.09M | 29.49M |
Research & Development | 1.78B | 116.00M | 102.70M | 645.03M | 226.47M | 143.04M | 85.50M |
Other Expenses | 188.00M | -524.30M | -128.80M | -893.21M | -223.60M | - | - |
Operating Expenses | 2.53B | 135.90M | 200.10M | -139.62M | 46.28M | 24.70M | 28.06M |
Interest Expense | 7.90M | 18.90M | 5.40M | 64.95M | 1.72M | 1.72M | 676.00K |
Selling & Marketing Expenses | 62.70M | 59.50M | 50.40M | 14.51M | 2.72M | 3.04M | 6.60M |
Cost & Expenses | 3.13B | 4.67B | 4.06B | 564.74M | 290.11M | 181.43M | 122.88M |
Income Tax | 255.80M | 3.52B | 4.75B | -161.00M | -268.00K | 600.00K | 45.00K |
Shares Outstanding (Basic) | 242.90M | 243.30M | 244.00M | 235.44M | 211.50M | 226.86M | 226.86M |
Shares Outstanding (Diluted) | 242.70M | 249.80M | 259.70M | 248.53M | 211.50M | 226.86M | 226.86M |
EPS (Basic) | 3.83 | 38.08 | 43.87 | 0.06 | -0.85 | -0.21 | -0.38 |
EPS (Diluted) | 3.83 | 37.09 | 41.21 | 0.06 | -0.85 | -0.21 | -0.38 |
EBITDA | 1.09B | 12.43B | 15.00B | -105.10M | -152.30M | -30.01M | -48.74M |
Depreciation & Amortization | 183.40M | 121.08M | 78.20M | 36.10M | 33.80M | 22.69M | 9.85M |